Paul Lubetkin, Executive VP & General Counsel at Pharmasset Inc (VRUS), bought 500 shares at $10.14 ($5K) on 2009-02-25, disclosed to the SEC on 2009-02-26.
Open-market purchase of $5k VRUS by Executive VP & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.14 | 125 | $1K | 24.1% |
| 2 | $10.64 | 200 | $2K | 40.5% |
| 3 | $10.65 | 175 | $2K | 35.4% |
| Total | $10.52 avg | 500 | $5K | 100% |